{"id":"antiviral-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antiviral drugs work through multiple mechanisms depending on the specific agent and target virus, including inhibition of viral polymerases, proteases, or reverse transcriptases that are critical for viral reproduction. By blocking these viral-specific enzymes or proteins, antivirals prevent the virus from replicating within host cells and reduce viral load. This allows the immune system to better control the infection and reduces disease severity and transmission.","oneSentence":"Antiviral therapy inhibits viral replication by targeting viral enzymes or proteins essential for the virus lifecycle.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:40:44.699Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Viral infections (specific indication not specified)"}]},"trialDetails":[{"nctId":"NCT07371650","phase":"PHASE2","title":"This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza","status":"ACTIVE_NOT_RECRUITING","sponsor":"Traws Pharma, Inc.","startDate":"2025-12-15","conditions":"Influenza","enrollment":105},{"nctId":"NCT07361796","phase":"NA","title":"The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain, Postherpetic Neuralgia","enrollment":832},{"nctId":"NCT07178366","phase":"NA","title":"Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-05-10","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":56},{"nctId":"NCT07493109","phase":"PHASE3","title":"Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP","status":"RECRUITING","sponsor":"Ou Bai, MD/PHD","startDate":"2026-05-30","conditions":"Diffuse Large B-Cell Lymphoma (DLBCL)","enrollment":200},{"nctId":"NCT03520660","phase":"PHASE4","title":"People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2018-10-19","conditions":"Diabetes Mellitus, Hepatitis C, Chronic, Cardiovascular Diseases","enrollment":121},{"nctId":"NCT01581554","phase":"","title":"Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2011-05-18","conditions":"Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative","enrollment":15},{"nctId":"NCT03180216","phase":"PHASE1","title":"T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's National Research Institute","startDate":"2017-02-15","conditions":"Viral Infections, Bone Marrow Transplant Infection","enrollment":32},{"nctId":"NCT07392372","phase":"PHASE1","title":"A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-09","conditions":"HIV -1 Infection","enrollment":61},{"nctId":"NCT07307170","phase":"NA","title":"The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Mirogabalin, Pain","enrollment":750},{"nctId":"NCT07481032","phase":"NA","title":"Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2026-04-01","conditions":"Cirrhosis, Liver, Hepatocellular Carcinoma (HCC), HEPATITIS B CHRONIC","enrollment":1034},{"nctId":"NCT07393685","phase":"","title":"Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-08-01","conditions":"Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Influenza, Human, Virus Diseases","enrollment":300},{"nctId":"NCT07202546","phase":"PHASE2","title":"A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)","status":"RECRUITING","sponsor":"ViiV Healthcare","startDate":"2026-02-11","conditions":"HIV Infections","enrollment":150},{"nctId":"NCT07419373","phase":"PHASE2","title":"ARN-75039 Lassa Fever Treatment in West Africa","status":"RECRUITING","sponsor":"Arisan Therapeutics, Inc.","startDate":"2026-02","conditions":"Lassa Fever","enrollment":135},{"nctId":"NCT06468995","phase":"NA","title":"Antiviral Long Acting Drugs Landing in People Living With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2024-12-02","conditions":"HIV, Antiviral Agents","enrollment":120},{"nctId":"NCT05807048","phase":"PHASE2","title":"Daratumumab in STK11 Mutated NSCLC","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2023-06-01","conditions":"Non-small Cell Lung Cancer With STK11/LKB1 Mutation","enrollment":8},{"nctId":"NCT07459426","phase":"","title":"Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)","status":"NOT_YET_RECRUITING","sponsor":"Yaşar Bayındır, MD","startDate":"2026-03-15","conditions":"Hepatitis B, Chronic","enrollment":700},{"nctId":"NCT03586284","phase":"PHASE2, PHASE3","title":"Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2020-03-15","conditions":"Cytomegalovirus Anterior Uveitis","enrollment":51},{"nctId":"NCT07341386","phase":"PHASE4","title":"Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-04-01","conditions":"Autoimmune Rheumatic Diseases, Recurrent Herpes Simplex, Prevention","enrollment":62},{"nctId":"NCT07001319","phase":"PHASE1","title":"Study of GS-3242 in Participants With HIV-1; Substudy-05","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2025-05-29","conditions":"HIV-1-infection","enrollment":30},{"nctId":"NCT04648280","phase":"PHASE1, PHASE2","title":"Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance","status":"ACTIVE_NOT_RECRUITING","sponsor":"PENTA Foundation","startDate":"2022-06-30","conditions":"HIV Infections With Multi Drug Resistant Virus","enrollment":60},{"nctId":"NCT06668025","phase":"NA","title":"MxA-Guided Antiviral Treatment in Respiratory Viral Infections","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2024-12-12","conditions":"Respiratory Viral Infections, Influenza, SARS CoV-2","enrollment":86},{"nctId":"NCT07450365","phase":"PHASE4","title":"Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection","status":"NOT_YET_RECRUITING","sponsor":"Hu Bofei","startDate":"2026-02-15","conditions":"Congenital CMV Infection","enrollment":150},{"nctId":"NCT04979728","phase":"","title":"HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2021-05-27","conditions":"HIV Treatment, HIV Prevention","enrollment":150},{"nctId":"NCT07443501","phase":"","title":"Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-14","conditions":"CMV Infection","enrollment":1114},{"nctId":"NCT02932150","phase":"PHASE2","title":"Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2016-11","conditions":"Chronic Hepatitis B","enrollment":150},{"nctId":"NCT06817889","phase":"PHASE2","title":"Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-12-23","conditions":"Hematopoietic and Lymphatic System Neoplasm, Autoimmune Disease, Respiratory Syncytial Virus Infection","enrollment":60},{"nctId":"NCT06779058","phase":"","title":"MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B","status":"RECRUITING","sponsor":"Shengjing Hospital","startDate":"2025-01-01","conditions":"Chronic Hepatitis B, Liver Fibrosis","enrollment":600},{"nctId":"NCT07430683","phase":"PHASE4","title":"Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2024-03-01","conditions":"Cytomegalovirus Infections","enrollment":68},{"nctId":"NCT07425587","phase":"","title":"Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Bluejay Diagnostics, Inc.","startDate":"2026-04-12","conditions":"Sepsis, Septic Shock","enrollment":450},{"nctId":"NCT05587894","phase":"PHASE2","title":"OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial","status":"RECRUITING","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2023-04-27","conditions":"COVID-19, Immunodeficiency","enrollment":256},{"nctId":"NCT02283112","phase":"","title":"Validation of Drug Assays in Various Biological Matrices","status":"RECRUITING","sponsor":"University of Liverpool","startDate":"2014-10","conditions":"Infection","enrollment":100},{"nctId":"NCT05648448","phase":"PHASE2","title":"A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2023-02-22","conditions":"Influenza, Influenza, Human","enrollment":3000},{"nctId":"NCT05041907","phase":"PHASE2","title":"Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2021-09-30","conditions":"COVID-19","enrollment":3800},{"nctId":"NCT07406217","phase":"PHASE2","title":"OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients","status":"RECRUITING","sponsor":"Calmy Alexandra","startDate":"2023-04-27","conditions":"COVID-19, Immunodeficiency","enrollment":256},{"nctId":"NCT05708508","phase":"PHASE3","title":"Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2024-03-28","conditions":"Kidney Transplant Infection","enrollment":144},{"nctId":"NCT07235683","phase":"PHASE4","title":"Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-12-24","conditions":"CMV, Lung Transplant Recipient","enrollment":40},{"nctId":"NCT05653232","phase":"NA","title":"Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-04-19","conditions":"HCV","enrollment":120},{"nctId":"NCT07409259","phase":"EARLY_PHASE1","title":"PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":20},{"nctId":"NCT04431245","phase":"","title":"Stopping Antiviral Treatment in Chronic Hepatitis B","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2021-06-01","conditions":"Chronic Hepatitis b","enrollment":54},{"nctId":"NCT06160128","phase":"","title":"Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-09-26","conditions":"COVID-19, SARS-CoV-2 Infection, RSV, Influenza","enrollment":400000},{"nctId":"NCT06061536","phase":"PHASE2","title":"Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients.","status":"COMPLETED","sponsor":"Shanxi Kangbao Biological Product Co., Ltd.","startDate":"2023-11-02","conditions":"HIV","enrollment":64},{"nctId":"NCT07072793","phase":"","title":"A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-10-31","conditions":"COVID-19 (Coronavirus Disease 2019)","enrollment":131005},{"nctId":"NCT07378046","phase":"NA","title":"The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain","enrollment":750},{"nctId":"NCT07378059","phase":"NA","title":"The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain","enrollment":750},{"nctId":"NCT01651403","phase":"PHASE3","title":"Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2012-12-06","conditions":"Chronic Hepatitis B","enrollment":90},{"nctId":"NCT04605679","phase":"NA","title":"Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Loma Linda University","startDate":"2020-05-06","conditions":"Kidney Failure","enrollment":31},{"nctId":"NCT01199562","phase":"","title":"Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2010-12","conditions":"Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia","enrollment":153},{"nctId":"NCT07370402","phase":"NA","title":"The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain","enrollment":750},{"nctId":"NCT07370389","phase":"NA","title":"The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain","enrollment":750},{"nctId":"NCT07090759","phase":"PHASE3","title":"To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment","status":"RECRUITING","sponsor":"Fujian Akeylink Biotechnology Co., Ltd.","startDate":"2025-07-24","conditions":"Chronic Hepatitis b","enrollment":526},{"nctId":"NCT07361809","phase":"NA","title":"The Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain","enrollment":750},{"nctId":"NCT03383419","phase":"PHASE2","title":"Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients","status":"RECRUITING","sponsor":"Baylor Research Institute","startDate":"2018-03-20","conditions":"Heart Failure","enrollment":15},{"nctId":"NCT07344246","phase":"NA","title":"Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-02-01","conditions":"Herpes Zoster Pain","enrollment":954},{"nctId":"NCT07307976","phase":"NA","title":"The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain","enrollment":750},{"nctId":"NCT02797522","phase":"PHASE1","title":"A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2016-06","conditions":"Hepatitis B","enrollment":47},{"nctId":"NCT07329686","phase":"PHASE1, PHASE2","title":"Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-10-01","conditions":"Herpes Simplex Keratitis, Corneal Neovascularization","enrollment":100},{"nctId":"NCT01854775","phase":"PHASE2, PHASE3","title":"Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2013-05-06","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":129},{"nctId":"NCT05999435","phase":"PHASE2, PHASE3","title":"Study of LAU-7b for the Treatment of Long COVID in Adults","status":"COMPLETED","sponsor":"Laurent Pharmaceuticals Inc.","startDate":"2023-11-15","conditions":"Long COVID","enrollment":272},{"nctId":"NCT06999603","phase":"PHASE2","title":"Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection","status":"RECRUITING","sponsor":"Synairgen Research Ltd.","startDate":"2025-09-02","conditions":"Viral Pneumonia","enrollment":550},{"nctId":"NCT04453917","phase":"NA","title":"Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2021-02-23","conditions":"Progressive Multifocal Leukoencephalopathy","enrollment":22},{"nctId":"NCT02349126","phase":"PHASE2","title":"Study of ARC-520 in Patient With Chronic Hepatitis B Virus","status":"WITHDRAWN","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-02","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT06562803","phase":"NA","title":"Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis","status":"RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2024-09-27","conditions":"Acute-On-Chronic Liver Failure, Sepsis","enrollment":60},{"nctId":"NCT05381454","phase":"PHASE1, PHASE2","title":"An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-04-28","conditions":"Respiratory Viral Infection, Antiviral Treatment, COVID-19","enrollment":80},{"nctId":"NCT04690933","phase":"","title":"AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2020-09-24","conditions":"Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Antivirals","enrollment":400},{"nctId":"NCT07274345","phase":"","title":"Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients","status":"NOT_YET_RECRUITING","sponsor":"Amira Mohamed Zidan","startDate":"2025-12-01","conditions":"Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection","enrollment":2000},{"nctId":"NCT06749054","phase":"PHASE2","title":"Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2025-03-26","conditions":"HIV-1-infection","enrollment":12},{"nctId":"NCT05595369","phase":"PHASE2","title":"RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2023-07-26","conditions":"Long COVID, Long Covid19","enrollment":963},{"nctId":"NCT06385327","phase":"PHASE1","title":"A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assembly Biosciences","startDate":"2024-05-30","conditions":"Recurrent Genital Herpes Simplex Type 2","enrollment":115},{"nctId":"NCT05797714","phase":"NA","title":"The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2022-06-08","conditions":"HBV Infection, Chronic Hepatitis b","enrollment":200},{"nctId":"NCT07189377","phase":"PHASE4","title":"Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-09-24","conditions":"Hepatitis B Virus (HBV), Lung Transplant Recipient","enrollment":20},{"nctId":"NCT04417257","phase":"PHASE2, PHASE3","title":"Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults","status":"TERMINATED","sponsor":"Laurent Pharmaceuticals Inc.","startDate":"2020-08-18","conditions":"COVID-19 Disease","enrollment":351},{"nctId":"NCT06987318","phase":"PHASE1","title":"A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-02-15","conditions":"HIV-1-infection","enrollment":40},{"nctId":"NCT07225972","phase":"PHASE3","title":"Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone","status":"NOT_YET_RECRUITING","sponsor":"New York Medical College","startDate":"2026-12-01","conditions":"CMV, AdV Infection, AdV Reactivation","enrollment":69},{"nctId":"NCT05484895","phase":"NA","title":"Mobile Health Intervention to Increase HIV Testing and Linkage to Care","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-12-15","conditions":"HIV","enrollment":1800},{"nctId":"NCT05957913","phase":"PHASE2","title":"Effects of Antiviral Therapies on Epstein-Barr Virus Replication","status":"ENROLLING_BY_INVITATION","sponsor":"Massachusetts General Hospital","startDate":"2023-06-05","conditions":"Multiple Sclerosis","enrollment":50},{"nctId":"NCT05275998","phase":"PHASE1, PHASE2","title":"TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals","status":"COMPLETED","sponsor":"TaiMed Biologics Inc.","startDate":"2022-07-05","conditions":"HIV-1-infection","enrollment":51},{"nctId":"NCT07115368","phase":"PHASE1","title":"Study of GS-1219 in Participants With HIV-1","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2025-08-11","conditions":"HIV-1-infection","enrollment":4},{"nctId":"NCT06061081","phase":"PHASE2","title":"A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1","status":"TERMINATED","sponsor":"ViiV Healthcare","startDate":"2023-12-21","conditions":"HIV Infections","enrollment":21},{"nctId":"NCT04704024","phase":"PHASE3","title":"Reducing Vertical Transmission of Hepatitis B in Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2021-09-03","conditions":"Hepatitis B Infection","enrollment":450},{"nctId":"NCT04896255","phase":"","title":"Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2020-09-09","conditions":"Chronic Hepatitis b","enrollment":33000},{"nctId":"NCT04782375","phase":"PHASE4","title":"Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asan Medical Center","startDate":"2021-09-01","conditions":"Hepatitis B, Chronic","enrollment":140},{"nctId":"NCT07203664","phase":"PHASE4","title":"Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitario La Paz","startDate":"2025-10-30","conditions":"Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients","enrollment":30},{"nctId":"NCT06039579","phase":"PHASE2","title":"Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2023-10-25","conditions":"HIV Infections","enrollment":44},{"nctId":"NCT00146094","phase":"NA","title":"Bone Mineral Density (BMD) in HIV Infection","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2003-03","conditions":"Osteopenia, Osteoporosis","enrollment":44},{"nctId":"NCT06680232","phase":"PHASE1","title":"Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B","status":"RECRUITING","sponsor":"Precision BioSciences, Inc.","startDate":"2024-11-14","conditions":"HEPATITIS B CHRONIC","enrollment":45},{"nctId":"NCT05013632","phase":"","title":"COVID-19 International Drug Pregnancy Registry","status":"RECRUITING","sponsor":"Pregistry","startDate":"2021-12-01","conditions":"Covid19","enrollment":2000},{"nctId":"NCT06762730","phase":"PHASE4","title":"Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals","status":"RECRUITING","sponsor":"Hadassah Medical Organization","startDate":"2024-12-09","conditions":"HIV Infected Individuals, Osteopenia","enrollment":110},{"nctId":"NCT04863703","phase":"","title":"Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hannover Medical School","startDate":"2021-05-07","conditions":"Hepatitis D, Hepatitis B, Portal Hypertension","enrollment":11},{"nctId":"NCT06683937","phase":"","title":"Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-12-01","conditions":"Immunocompromised Patients, SARS-CoV-2 Disease","enrollment":300},{"nctId":"NCT06814275","phase":"NA","title":"Project neuroARTEMIS","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-04-29","conditions":"Stimulant Use, Human Immunodeficiency Virus (HIV), Depression","enrollment":189},{"nctId":"NCT05853718","phase":"PHASE4","title":"Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women","status":"RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2021-05-06","conditions":"Chronic Hepatitis b, Tenofovir Alafenamide Fumarate","enrollment":50},{"nctId":"NCT07145268","phase":"PHASE2","title":"Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2025-09-01","conditions":"Liver Fibroses, HBV (Hepatitis B Virus)","enrollment":44},{"nctId":"NCT07133763","phase":"PHASE1, PHASE2","title":"Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders.","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2025-09-01","conditions":"EBV-Associated Lymphoproliferative Disorders, PD-1 Inhibitor, Tenofovir","enrollment":50},{"nctId":"NCT03754803","phase":"","title":"Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2018-11-08","conditions":"HIV Infections","enrollment":376},{"nctId":"NCT06031272","phase":"PHASE1","title":"Pausing Antiretroviral Treatment Under Structured Evaluation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2024-05-28","conditions":"HIV-1-infection","enrollment":32},{"nctId":"NCT07120750","phase":"","title":"Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Third People's Hospital","startDate":"2025-09-01","conditions":"Hepatocellular Carcinoma (HCC), Chronic Hepatitis B","enrollment":332},{"nctId":"NCT06615921","phase":"","title":"A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2024-10-14","conditions":"Cytomegalovirus (CMV)","enrollment":265},{"nctId":"NCT04473053","phase":"PHASE1, PHASE2","title":"DEFINE - Evaluating Therapies for COVID-19","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2020-07-03","conditions":"COVID-19","enrollment":71},{"nctId":"NCT06873633","phase":"PHASE2","title":"Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV","status":"RECRUITING","sponsor":"PENTA Foundation","startDate":"2025-07-16","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT07079150","phase":"","title":"Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study","status":"RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2025-01-01","conditions":"Hepatitis B, Chronic (CHB), Hepatitis B, Hepatitis B Virus (HBV)","enrollment":1500}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BRONCHOPNEUMONIA"},{"count":1,"reaction":"CD4 LYMPHOCYTES DECREASED"},{"count":1,"reaction":"CYTOMEGALOVIRUS COLITIS"},{"count":1,"reaction":"DIARRHOEA"},{"count":1,"reaction":"DISSEMINATED CYTOMEGALOVIRAL INFECTION"},{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"HEPATIC FAILURE"},{"count":1,"reaction":"HEPATITIS"},{"count":1,"reaction":"HYPOKALAEMIA"},{"count":1,"reaction":"PNEUMONITIS"}],"_approvalHistory":[],"publicationCount":17021,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Combivir"],"phase":"marketed","status":"active","brandName":"antiviral therapy","genericName":"antiviral therapy","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antiviral therapy inhibits viral replication by targeting viral enzymes or proteins essential for the virus lifecycle. Used for Viral infections (specific indication not specified).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}